MigraineMind research summary
Acute treatment of migraine in children aged 6-11: Real-world analysis of remote electrical neuromodulation (REN).
Ann Child Neurol Soc | 2024
Clinical trialSummary
Migraine affects many children and adolescents, causing significant challenges in their lives. Currently, only one medication is approved for treating migraines in kids aged 6-12. Remote electrical neuromodulation (REN) is a new, non-drug treatment option. It involves a wearable device that helps manage migraine symptoms. This study looked at how safe and effective REN is for children aged 6-11. Researchers gathered data from 293 participants, with a median age of 11 years. Most participants were girls, making up 73.7% of the group. In total, they completed 5493 treatments using the REN device. Remarkably, no adverse events were reported during this study. The results showed that at least 50% of the treatments provided significant relief from headache pain and other migraine-related symptoms. This suggests REN could be a promising option for treating migraines in younger children. Clinical relevance: This study indicates that REN is safe and effective for treating migraines in children, potentially offering a valuable alternative to traditional medications.
Key Learning Points
- Migraine is a common issue for children and adolescents, significantly impacting their daily lives.
- Currently, there is only one medication approved for treating migraines in children aged 6-12.
- Remote electrical neuromodulation is a new, non-drug treatment that uses a wearable device to help manage migraines.
- In a study of 293 children aged 6-11, no adverse events were reported with the use of the REN device.
- At least 50% of treatments with the REN device provided significant relief from headache pain and migraine symptoms.
Research Informatics
SINGLE-ARM TRIAL
REN may be safe and effective for child migraines.
safetyNo adverse events reported
conditionMigraine in children aged 6-11
populationChildren aged 6-11 years with migraine
sample Size293
primary OutcomeDevice safety
designProspective data collection
Related migraine research topics
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.